InsidersTradesSigma
Follow the 서울제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 서울제약 has published 2 reports. The latest transaction was disclosed on 30 November 2022 (Purchase). Among the most active insiders: 신봉환. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
서울제약 es una empresa de atención médica y farmacéutica que cotiza en el mercado XKRX. Se especializa en la fabricación y distribución de productos farmacéuticos.